Depletion of Cutaneous Macrophages and Dendritic Cells Promotes Growth of Basal Cell Carcinoma in Mice
Author(s) -
Simone König,
Frauke Nitzki,
Anja Uhmann,
Kai Dittmann,
Jennifer Theiss-Suennemann,
Markus K. A. Herrmann,
Holger M. Reichardt,
Reto A. Schwendener,
Tobias Pukrop,
Walter SchulzSchaeffer,
Heidi Hahn
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0093555
Subject(s) - basal cell carcinoma , cancer research , tumor microenvironment , stroma , biology , dendritic cell , conditional gene knockout , microbiology and biotechnology , chemistry , pathology , immunology , immune system , tumor cells , medicine , immunohistochemistry , gene , phenotype , basal cell , biochemistry
Basal cell carcinoma (BCC) belongs to the group of non-melanoma skin tumors and is the most common tumor in the western world. BCC arises due to mutations in the tumor suppressor gene Patched1 ( Ptch ). Analysis of the conditional Ptch knockout mouse model for BCC reveals that macrophages and dendritic cells (DC) of the skin play an important role in BCC growth restraining processes. This is based on the observation that a clodronate-liposome mediated depletion of these cells in the tumor-bearing skin results in significant BCC enlargement. The depletion of these cells does not modulate Ki67 or K10 expression, but is accompanied by a decrease in collagen-producing cells in the tumor stroma. Together, the data suggest that cutaneous macrophages and DC in the tumor microenvironment exert an antitumor effect on BCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom